SCHEMBL7066053

SCHEMBL7066053

CC(C)Oc1ccccc1SC(Cc1ccccc1OCc1cnc2ccccc2c1)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.38
PDE10A Q9Y233 1/20 0.37
PTGER1 P34995 2/20 0.36
PTGER4 P35408 2/20 0.36
PTGER3 P43115 2/20 0.36
PTGER2 P43116 2/20 0.36
MME P08473 1/20 0.36
ACE P12821 1/20 0.36
CPA1 P15085 1/20 0.36
ACE2 Q9BYF1 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
ACACB O00763 1/20 0.35
SCN9A Q15858 1/20 0.35
SIRT2 Q8IXJ6 1/20 0.35
ITGA4 P13612 1/20 0.35
ITGB7 P26010 1/20 0.35
CFD P00746 1/20 0.34
CGAS Q8N884 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7069231 0.86 PPARG (0.39) PDE10APTGER1PTGER4PTGER3PTGER2
SCHEMBL7130373 0.84 FFAR4 (0.40) FFAR4PDE10APTGER1PTGER4PTGER3
SCHEMBL7069255 0.83 MME (0.39) PDE10APTGER1PTGER4PTGER3PTGER2
SCHEMBL7070136 0.81 KMT2A (0.42) PTGER1SMN1; SMN2HTTFAAH
SCHEMBL7604848 0.80 MGAM (0.43) PDE10APTGER1PTGER4PTGER3PTGER2
SCHEMBL7066080 0.78 SMN1; SMN2 (0.41) PDE10APTGER1PTGER4PTGER3PTGER2
SCHEMBL7069510 0.78 TRPV1 (0.41) PDE10AMMEACECPA1ACE2
SCHEMBL7067687 0.78 MGAM (0.41) PDE10APTGER1PTGER4PTGER3PTGER2
SCHEMBL7068772 0.78 PDE10A (0.42) PDE10APTGER1PTGER4PTGER3PTGER2
SCHEMBL7065979 0.77 MME (0.42) PDE10APTGER1PTGER4PTGER3PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030212100-A1 Quinoline derivatives and medicinal use thereof MITSUI CHEMICALS, INC. (JP) 2003-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212100-A1 Quinoline derivatives and medicinal use thereof PPARG, PPARD, PPARA FFAR4 734/4885PDE10A 2389/4885PTGER1 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.